Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis

April 26, 2017 updated by: Saeed Asgary, Shahid Beheshti University of Medical Sciences

Vital Pulp Therapy for Management of Irreversible Pulpitis in Human Permanent Teeth: A Randomized Clinical Trial.

To compare the effect of different VPT methods using Calcium Enriched Mixture (CEM) cement for management of human dental pulp with irreversible pulpitis.

Study Overview

Detailed Description

The purpose of this randomized clinical trial is to demonstrate the effect of four methods of Vital Pulp Therapy (VPT) using a new endodontic bio-material [calcium enriched mixture (CEM) cement] in pain relief as well as clinical/radiographic success, for management of irreversible pulpitis of human permanent teeth.

Study Type

Interventional

Enrollment (Actual)

302

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Carious permanent vital mature molar tooth with closed apex (with preoperative X-ray)
  2. Positive response to EPT or cold test
  3. patients willing to participate in study
  4. Healthy subjects; absence of any systematic disorder
  5. Age ≥ 10 years old
  6. Both gender
  7. Written informed consent

Exclusion Criteria:

  1. Moderate or severe periodontitis; pockets >3mm
  2. None restorable tooth
  3. Internal or external root resorption
  4. Root canal calcification
  5. Non vital pulps
  6. Analgesic taken within the last 8h
  7. Active systemic disease
  8. Pregnancy or nursing
  9. History of opioid addiction/abuse
  10. Temporary residency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Indirect pulp capping (IPC)
Indirect pulp capping

Procedure: IPC

The IPC will be performed as follow:

  • Anesthesia
  • isolation the tooth
  • access to the lesion
  • incomplete removal of carious tissue from the cavity walls
  • indirect pulp capping with ≈2 mm layer calcium enriched mixture cement
  • permanent filling with sandwich technique
Other Names:
  • Indirect pulp capping
EXPERIMENTAL: Direct pulp capping (DPC)
Direct pulp capping

Procedure: DPC

The DPC will be performed as follow:

  • Anesthesia
  • isolation the tooth
  • access to the lesion
  • complete removal of carious tissue from the cavity walls result in pulp exposure
  • preparation of clot-free pulpal mound
  • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
  • permanent filling with sandwich technique
Other Names:
  • Direct pulp capping
EXPERIMENTAL: Miniature pulpotomy (MP)
Miniature pulpotomy

Procedure: MP

The MP will be performed as follow:

  • Anesthesia
  • isolation the tooth
  • access to the lesion
  • complete removal of carious tissue from the cavity walls result in pulp exposure
  • intentionally removal of pulp horn (≈1 mm)
  • preparation of clot-free pulpal mound
  • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
  • permanent filling with sandwich technique
Other Names:
  • Miniature pulpotomy
EXPERIMENTAL: Full pulpotomy (FP)
Full pulpotomy

Procedure: FP

The FP will be performed as follow:

  • Anesthesia
  • isolation the tooth
  • access to the lesion
  • complete removal of carious tissue from the cavity walls result in pulp exposure
  • pulpotomy
  • preparation of clot-free pulpal mound
  • direct pulp capping with ≈2 mm layer calcium enriched mixture cement
  • permanent filling with sandwich technique
Other Names:
  • Full pulpotomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical and radiographical success rates (%) of each treatment group
Time Frame: 1 year

The outcome of clinical success/failure is determined by subjective symptoms and objective observation of inflammation/infection.

The outcome of radiographic success is classified by using a modification of the Strindberg criteria.

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Assessment of Pain with questionnaire
Time Frame: 6-months
Pain assessment is carried out using the pain Numerical Rating Scale (NRS) with ratings between 0 to 9. Pain assessment is made up to 7 days. One NRS form is given to each patient to complete.
6-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mohammad Jafar Eghbal, DDS, MS, Iran Center For Dental Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (ACTUAL)

March 1, 2014

Study Completion (ACTUAL)

December 1, 2016

Study Registration Dates

First Submitted

March 14, 2012

First Submitted That Met QC Criteria

March 21, 2012

First Posted (ESTIMATE)

March 22, 2012

Study Record Updates

Last Update Posted (ACTUAL)

April 28, 2017

Last Update Submitted That Met QC Criteria

April 26, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Irreversible Pulpitis

Clinical Trials on Indirect pulp capping (IPC)

3
Subscribe